Literature DB >> 10986043

A mutation in the rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males.

I Meloni1, M Bruttini, I Longo, F Mari, F Rizzolio, P D'Adamo, K Denvriendt, J P Fryns, D Toniolo, A Renieri.   

Abstract

Heterozygous mutations in the X-linked MECP2 gene cause Rett syndrome, a severe neurodevelopmental disorder of young females. Only one male presenting an MECP2 mutation has been reported; he survived only to age 1 year, suggesting that mutations in MECP2 are male lethal. Here we report a three-generation family in which two affected males showed severe mental retardation and progressive spasticity, previously mapped in Xq27.2-qter. Two obligate carrier females showed either normal or borderline intelligence, simulating an X-linked recessive trait. The two males and the two obligate carrier females presented a mutation in the MECP2 gene, demonstrating that, in males, MECP2 can be responsible for severe mental retardation associated with neurological disorders.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10986043      PMCID: PMC1287900          DOI: 10.1086/303078

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  16 in total

1.  MECP2 mutations account for most cases of typical forms of Rett syndrome.

Authors:  T Bienvenu; A Carrié; N de Roux; M C Vinet; P Jonveaux; P Couvert; L Villard; A Arzimanoglou; C Beldjord; M Fontes; M Tardieu; J Chelly
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

Review 2.  Methyl-CpG-binding protein 2 mutations in Rett syndrome.

Authors:  I B Van den Veyver; H Y Zoghbi
Journal:  Curr Opin Genet Dev       Date:  2000-06       Impact factor: 5.578

3.  Mutation screening in Rett syndrome patients.

Authors:  F Xiang; S Buervenich; P Nicolao; M E Bailey; Z Zhang; M Anvret
Journal:  J Med Genet       Date:  2000-04       Impact factor: 6.318

4.  Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes.

Authors:  R E Amir; I B Van den Veyver; R Schultz; D M Malicki; C Q Tran; E J Dahle; A Philippi; L Timar; A K Percy; K J Motil; O Lichtarge; E O Smith; D G Glaze; H Y Zoghbi
Journal:  Ann Neurol       Date:  2000-05       Impact factor: 10.422

5.  Preserved speech variant is allelic of classic Rett syndrome.

Authors:  C De Bona; M Zappella; G Hayek; I Meloni; F Vitelli; M Bruttini; R Cusano; P Loffredo; I Longo; A Renieri
Journal:  Eur J Hum Genet       Date:  2000-05       Impact factor: 4.246

6.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.

Authors:  R E Amir; I B Van den Veyver; M Wan; C Q Tran; U Francke; H Y Zoghbi
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

7.  Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots.

Authors:  M Wan; S S Lee; X Zhang; I Houwink-Manville; H R Song; R E Amir; S Budden; S Naidu; J L Pereira; I F Lo; H Y Zoghbi; N C Schanen; U Francke
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

8.  Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients.

Authors:  P Huppke; F Laccone; N Krämer; W Engel; F Hanefeld
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

9.  Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location.

Authors:  J P Cheadle; H Gill; N Fleming; J Maynard; A Kerr; H Leonard; M Krawczak; D N Cooper; S Lynch; N Thomas; H Hughes; M Hulten; D Ravine; J R Sampson; A Clarke
Journal:  Hum Mol Genet       Date:  2000-04-12       Impact factor: 6.150

10.  Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation.

Authors:  R C Allen; H Y Zoghbi; A B Moseley; H M Rosenblatt; J W Belmont
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

View more
  44 in total

Review 1.  Rett syndrome and the MECP2 gene.

Authors:  T Webb; F Latif
Journal:  J Med Genet       Date:  2001-04       Impact factor: 6.318

2.  MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin.

Authors:  R Trappe; F Laccone; J Cobilanschi; M Meins; P Huppke; F Hanefeld; W Engel
Journal:  Am J Hum Genet       Date:  2001-04-17       Impact factor: 11.025

3.  MECP2 mutation in non-fatal, non-progressive encephalopathy in a male.

Authors:  B Imessaoudene; J P Bonnefont; G Royer; V Cormier-Daire; S Lyonnet; G Lyon; A Munnich; J Amiel
Journal:  J Med Genet       Date:  2001-03       Impact factor: 6.318

4.  X-linked mental retardation with seizures and carrier manifestations is caused by a mutation in the creatine-transporter gene (SLC6A8) located in Xq28.

Authors:  Kimberly A Hahn; Gajja S Salomons; Darci Tackels-Horne; Tim C Wood; Harold A Taylor; Richard J Schroer; Herbert A Lubs; Cornelis Jakobs; Rick L Olson; Kenton R Holden; Roger E Stevenson; Charles E Schwartz
Journal:  Am J Hum Genet       Date:  2002-03-15       Impact factor: 11.025

Review 5.  Rett syndrome and MeCP2: linking epigenetics and neuronal function.

Authors:  Mona D Shahbazian; Huda Y Zoghbi
Journal:  Am J Hum Genet       Date:  2002-11-19       Impact factor: 11.025

Review 6.  X linked mental retardation: a clinical guide.

Authors:  F L Raymond
Journal:  J Med Genet       Date:  2005-08-23       Impact factor: 6.318

Review 7.  Rett syndrome: clinical review and genetic update.

Authors:  L S Weaving; C J Ellaway; J Gécz; J Christodoulou
Journal:  J Med Genet       Date:  2005-01       Impact factor: 6.318

Review 8.  Specific genetic disorders and autism: clinical contribution towards their identification.

Authors:  David Cohen; Nadège Pichard; Sylvie Tordjman; Clarisse Baumann; Lydie Burglen; Elsa Excoffier; Gabriela Lazar; Philippe Mazet; Clément Pinquier; Alain Verloes; Delphine Héron
Journal:  J Autism Dev Disord       Date:  2005-02

9.  Comparison of 12 reference genes for normalization of gene expression levels in Epstein-Barr virus-transformed lymphoblastoid cell lines and fibroblasts.

Authors:  Arjan P M de Brouwer; Hans van Bokhoven; Hannie Kremer
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

10.  MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number.

Authors:  Hsiao-Tuan Chao; Huda Y Zoghbi; Christian Rosenmund
Journal:  Neuron       Date:  2007-10-04       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.